Wełnicki, M.; Mamcarz, A.; Kuchar, E.; Mitkowski, P.; Jaroszewicz, J.; Tomasiewicz, K.; Gąsior, M.; Leszek, P.; Kamiński, K.A.; Wysocki, J.
The Impact of COVID-19 and the Practical Importance of Vaccinations and Nirmatrelvir/Ritonavir for Patients with Cardiovascular Disease. Vaccines 2025, 13, 554.
https://doi.org/10.3390/vaccines13060554
AMA Style
Wełnicki M, Mamcarz A, Kuchar E, Mitkowski P, Jaroszewicz J, Tomasiewicz K, Gąsior M, Leszek P, Kamiński KA, Wysocki J.
The Impact of COVID-19 and the Practical Importance of Vaccinations and Nirmatrelvir/Ritonavir for Patients with Cardiovascular Disease. Vaccines. 2025; 13(6):554.
https://doi.org/10.3390/vaccines13060554
Chicago/Turabian Style
Wełnicki, Marcin, Artur Mamcarz, Ernest Kuchar, Przemysław Mitkowski, Jerzy Jaroszewicz, Krzysztof Tomasiewicz, Mariusz Gąsior, Przemysław Leszek, Karol Adam Kamiński, and Jacek Wysocki.
2025. "The Impact of COVID-19 and the Practical Importance of Vaccinations and Nirmatrelvir/Ritonavir for Patients with Cardiovascular Disease" Vaccines 13, no. 6: 554.
https://doi.org/10.3390/vaccines13060554
APA Style
Wełnicki, M., Mamcarz, A., Kuchar, E., Mitkowski, P., Jaroszewicz, J., Tomasiewicz, K., Gąsior, M., Leszek, P., Kamiński, K. A., & Wysocki, J.
(2025). The Impact of COVID-19 and the Practical Importance of Vaccinations and Nirmatrelvir/Ritonavir for Patients with Cardiovascular Disease. Vaccines, 13(6), 554.
https://doi.org/10.3390/vaccines13060554